Risk-adapted moderate hypofractionation of prostate cancer

ConclusionRisk-adapted moderate hypofractionation is associated with low GI/GU toxicity. Given the higher rate of pelvic metastases in HR patients, slightly higher transient acute reactions should be outweighed by possible oncological benefits.

http://link.springer.com/10.1007/s00066-019-01477-y

Source: Strahlentherapie und Onkologie - May 27, 2019 Category: Cancer & Oncology Source Type: research